183 related articles for article (PubMed ID: 35393124)
1. Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations.
Corso G; Magnoni F; Nicastro V; Bagnardi V; Trovato CM; Veronesi P
Semin Oncol; 2022 Apr; 49(2):130-135. PubMed ID: 35393124
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
3. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
4. Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
Corso G; Davis JL; Strong VE
J Surg Oncol; 2024 May; 129(6):1082-1088. PubMed ID: 38389278
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
7. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
8. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
[TBL] [Abstract][Full Text] [Related]
9. Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect.
Schwarz A
Langenbecks Arch Surg; 2003 Mar; 388(1):27-32. PubMed ID: 12690477
[TBL] [Abstract][Full Text] [Related]
10. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.
Seevaratnam R; Coburn N; Cardoso R; Dixon M; Bocicariu A; Helyer L
Gastric Cancer; 2012 Sep; 15 Suppl 1():S153-63. PubMed ID: 22160243
[TBL] [Abstract][Full Text] [Related]
13. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.
Stillman MD; Kusche N; Toledano S; Hilfrank KJ; Yoon C; Gabre JT; Rustgi SD; Hur C; Kastrinos F; Ryeom SW; Yoon SS
J Surg Oncol; 2022 Dec; 126(8):1413-1422. PubMed ID: 36063148
[TBL] [Abstract][Full Text] [Related]
14. CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract][Full Text] [Related]
15. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience.
DiBrito SR; Blair AB; Prasath V; Habibi M; Harmon JW; Duncan MD
J Surg Res; 2020 Mar; 247():438-444. PubMed ID: 31685251
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers.
Bryant MK; Sillcox R; Grady WM; Oelschlager BK
Surg Endosc; 2023 Dec; 37(12):9373-9380. PubMed ID: 37644154
[TBL] [Abstract][Full Text] [Related]
17. Hereditary diffuse CDH1 positive gastric cancer. Prophylactic gastrectomy?
Sánchez Fuentes PA; Vidaña Márquez E; Velasco Albendea FJ
Med Clin (Barc); 2021 Jul; 157(1):46-48. PubMed ID: 32773164
[No Abstract] [Full Text] [Related]
18. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin germline mutation carriers: clinical management and genetic implications.
Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
[TBL] [Abstract][Full Text] [Related]
20. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
